CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal
BSE2872.90-14.65 (-0.51 %)
PREV CLOSE () 2887.55
OPEN PRICE () 2895.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5774
TODAY'S LOW / HIGH ()2853.70 2924.00
52 WK LOW / HIGH ()2295.1 3542.6
NSE2874.50-10.8 (-0.37 %)
PREV CLOSE() 2885.30
OPEN PRICE () 2902.80
BID PRICE (QTY) 2874.50 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 153975
TODAY'S LOW / HIGH() 2852.90 2924.00
52 WK LOW / HIGH ()2293.55 3540
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1995

Management Info :

Arvind Lal - Chairman - Managing Director

Registered Office :

Address : Block E,Sector 18,Rohini,
New Delhi,
Delhi-110085

Phone : 011-30258600

Registrar's Details : MUFG Intime India Pvt Ltd.
Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi
Listing : BSE, NSE
NEWS
26Nov Lal PathLabs informs about press release
Pursuant to Regulation 30 of the Listing Regulations, Lal PathLabs has i..
26Nov Dr. Lal PathLabs launches India’s firs
Dr. Lal PathLabs (DLPL) has launched India’s first dedicated Complement..
01Nov Dr. Lal PathLabs informs about press r
Dr. Lal PathLabs has informed that it attached the copy of newspaper adv..
01Nov Dr. Lal PathLabs informs about receipt
Pursuant to the provisions of Regulation 30 read with Schedule III of th..
24Sep Dr. Lal Pathlabs gets nod to acquire p
Dr. Lal Pathlabs has received approval from its Board to acquire immovab..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit14574973
Gross Profit 1948 6213
Operating Profit 23797770
Net Sales 699623516
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Apollo Hospital Ent. (BSE)
 7101.80 (1.31%)
M.Cap ( in Cr)
102112.99
Dr Agarwals Eye Hsp (BSE)
 5540.95 (0.79%)
M.Cap ( in Cr)
2677.85
Jupiter Life Line (BSE)
 1419.85 (1.35%)
M.Cap ( in Cr)
9309.39
Fortis Healthcare (BSE)
 874.30 (2.12%)
M.Cap ( in Cr)
66005.99
Indraprastha Medical (BSE)
 471.75 (3.30%)
M.Cap ( in Cr)
4324.67
Shareholding Pattern
PROMOTERS 53.21%
MUTUAL FUNDS/UTI 15.9%
NON-INSTITUTION 6.58%
FI/BANKS/INSURANCE 2.11%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX85267.66449.53 (0.53%)
NIFTY26046.95148.40 (0.57%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI